Veterinary Medicine Information website

HIPRAVIAR TRT-4 ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ

Authorised
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Inactivated
  • Newcastle disease virus, strain La Sota, Inactivated
  • Infectious bronchitis virus, strain H52, Inactivated
Download as PDF

Product identification

Medicine name:
HIPRAVIAR TRT-4 ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Active substance:
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Inactivated
  • Newcastle disease virus, strain La Sota, Inactivated
  • Infectious bronchitis virus, strain H52, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
    0.08
    gram(s)
    /
    1.00
    Dose
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Inactivated
    0.04
    gram(s)
    /
    1.00
    Dose
  • Newcastle disease virus, strain La Sota, Inactivated
    0.04
    gram(s)
    /
    1.00
    Dose
  • Infectious bronchitis virus, strain H52, Inactivated
    0.04
    gram(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 10274/01-07-2004/K-0090901
Date of authorisation status change: